Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bristol OTC Pravachol Study Enrollment Does Not Match Indication - FDA

This article was originally published in The Tan Sheet

Executive Summary

Bristol-Myers Squibb may need to better demonstrate consumers' ability to make self-selection choices based on appropriate cholesterol levels in order to convince FDA that an OTC version of Pravachol is approvable.
Advertisement

Related Content

Pravachol OTC Marketing Retailer Involvement Anticipated By BMS
OTC Statin Physician Follow-Up Label Comprehension Not Shown - FDA
OTC Pravachol Self-Selection Among Rx Users Needs More Study - NDAC
Pravachol OTC Marketing Retailer Involvement Anticipated By BMS
OTC Statin Physician Follow-Up Label Comprehension Not Shown - FDA
OTC Statin Physician Follow-Up Label Comprehension Not Shown - FDA
Pravachol OTC Marketing Retailer Involvement Anticipated By BMS
Mevacor Study Comparing Rx, OTC Use Is Among FDA Panel Suggestions
Mevacor Study Comparing Rx, OTC Use Is Among FDA Panel Suggestions

Topics

Advertisement
UsernamePublicRestriction

Register

PS091451

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel